This article is for educational and research purposes only. Nothing here constitutes medical advice. Consult a licensed healthcare provider before using any peptide.
What Is Ipamorelin?
Ipamorelin is a synthetic pentapeptide (five amino acids) that acts as a selective growth hormone secretagogue receptor (GHSR) agonist, also known as a ghrelin mimetic. Developed in the late 1990s by Novo Nordisk, it stimulates the pituitary gland to release growth hormone (GH) in a pulsatile manner that closely mimics the body's natural GH secretion pattern. Its selectivity is what sets it apart from other secretagogues — ipamorelin stimulates GH release without significantly affecting cortisol, prolactin, or aldosterone levels at therapeutic doses.
This selectivity profile earned ipamorelin the reputation as the "cleanest" growth hormone secretagogue in the peptide research community, making it a frequent starting point for those exploring GH optimization.
Mechanism of Action
Ipamorelin works through a distinct pathway from growth hormone-releasing hormones (GHRHs):
- GHSR activation: Binds to the growth hormone secretagogue receptor (GHS-R1a) on pituitary somatotroph cells, triggering GH release. This is the same receptor targeted by endogenous ghrelin.
- Pulsatile release: Unlike exogenous GH injection, ipamorelin stimulates the pituitary to produce its own GH, maintaining the natural pulsatile secretion pattern and preserving negative feedback mechanisms.
- Selective signaling: Research by Raun et al. (1998) demonstrated that ipamorelin does not stimulate ACTH or cortisol release even at doses 200 times the effective GH-releasing dose — a stark contrast to GHRP-6 and GHRP-2.
- Dose-dependent response: GH release scales linearly with dose up to a saturation point, giving practitioners predictable dose-response control.
Research-Backed Effects
Preclinical and limited clinical data suggest several effects of ipamorelin-induced GH elevation. Animal studies demonstrate improved bone mineral density and increased bone formation markers in ovariectomized rat models, suggesting potential value for age-related bone loss. Studies have also shown improvements in body composition, with favorable shifts toward lean mass gain and fat reduction when combined with appropriate training stimuli.
The GH pulses triggered by ipamorelin downstream increase IGF-1 production in the liver, which mediates many of growth hormone's anabolic and recovery effects. Sleep quality improvements are commonly reported anecdotally, likely related to GH's role in slow-wave sleep regulation.
Dosing Protocols
Common protocols reported in the research and peptide community include:
- Standard dose: 200-300 mcg per injection, administered subcutaneously
- Frequency: 1-3 times daily, with timing aligned to natural GH pulse windows (morning, post-workout, and before bed)
- Synergistic pairing: Often combined with CJC-1295 (no DAC) for amplified GH release — the GHRH+GHRP combination activates complementary pituitary signaling pathways
- Cycle length: 8-12 weeks is common, though some protocols extend longer with periodic breaks
- Timing: Best administered on an empty stomach, as elevated blood glucose and insulin blunt GH release
Side Effects
Ipamorelin is generally well-tolerated in the research literature. Reported side effects include transient head rush or lightheadedness shortly after injection, mild water retention, increased hunger (though much less than GHRP-6), and occasional injection site irritation. Because it does not elevate cortisol or prolactin, many of the side effects associated with less selective secretagogues are absent.
The Bottom Line
Ipamorelin's selective GH-releasing profile, predictable dose-response, and favorable side effect profile make it one of the most studied and widely used research peptides for GH optimization. It preserves the body's natural feedback mechanisms while providing meaningful GH elevation. However, comprehensive human clinical trials for anti-aging and body composition applications remain limited, and it is not FDA-approved for these uses.